Climb Bio, Inc. (CLYM) vs Fulgent Genetics, Inc. (FLGT)
A side-by-side comparison of Climb Bio, Inc. and Fulgent Genetics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CLYM
Climb Bio, Inc.
$11.05HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
FLGT
Fulgent Genetics, Inc.
$22.45HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — CLYM vs FLGT
growth of $100 · dividends reinvested · last 2yCLYM +41.1% (+18.8%/yr)FLGT +2.5% (+1.2%/yr)CLYM compounded faster over this window
CLYM FLGT
CLYM vs FLGT: by the numbers
- •FLGT is the larger company ($638M vs $633M market cap).
- •Both run net losses; CLYM's is the smaller (0.00% vs -26.05% net margin).
Metrics side by side
Valuation
| Metric | CLYM | FLGT |
|---|---|---|
| P/S ratio | N/A | 1.97 |
| P/B ratio | 2.64 | 0.64 |
Profitability
| Metric | CLYM | FLGT |
|---|---|---|
| Gross margin | 0.00% | 35.58% |
| Operating margin | 0.00% | -28.23% |
| Net margin | 0.00% | -26.05% |
| ROE | -24.06% | -8.42% |
| ROIC | -26.94% | -11.80% |
Growth (annualized)
| Metric | CLYM | FLGT |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -18.66% |
| Total return CAGR (5Y) | N/A | -22.38% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.